| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.38 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |